ORKA

Oruka Therapeutics, Inc.

Stock

$84.52+1.10 (+1.32%)Close Oct 2, 2026

Net income

Period	Ended	Net income	YoY	Filing
2025	Dec 31, 2025	−$105M	—	10-K, Mar 12, 2026
2023	Dec 31, 2023	−$5.3M	—	10-K, Feb 1, 2024
2022	Dec 31, 2022	−$9.9M	—	10-K, Feb 24, 2023
2021	Dec 31, 2021	−$19M	—	10-K, Mar 14, 2022
2020	Dec 31, 2020	−$9.7M	—	10-K, Mar 18, 2021
2019	Dec 31, 2019	−$5.5M	—	10-K, Feb 18, 2020
2018	Dec 31, 2018	−$7.9M	—	10-K, Feb 27, 2019
2017	Dec 31, 2017	−$18M	—	10-K, Mar 22, 2018
2016	Dec 31, 2016	−$16M	—	10-K, Mar 21, 2017
2015	Dec 31, 2015	−$11M	—	10-K, Mar 17, 2016
2014	Dec 31, 2014	−$9.7M	—	10-K, Mar 19, 2015
2013	Dec 31, 2013	−$6.9M	—	10-K, Mar 20, 2014
2012	Dec 31, 2012	−$4.3M	—	10-K, Mar 21, 2013
2011	Dec 31, 2011	−$5.4M	—	10-K, Mar 27, 2012
2010	Dec 31, 2010	−$8.4M	—	10-K, Mar 27, 2012
2009	Dec 31, 2009	−$9.1M	—	10-K, Mar 27, 2012
2008	Dec 31, 2008	−$19M	—	10-K, Mar 27, 2012
2007	Dec 31, 2007	−$14M	—	10-K, Mar 27, 2012
2006	Dec 31, 2006	−$5.2M	—	10-K, Mar 27, 2012
2005	Dec 31, 2005	−$1.5M	—	10-K, Mar 27, 2012
2004	Dec 31, 2004	−$511K	—	10-K, Mar 27, 2012